Cardiol Therapeutics Inc. (@CardiolRx) header
Cardiol Therapeutics Inc. (@CardiolRx) profile picture

Late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease NASDAQ $CRDL TSX $CRDL

Toronto, Ontario
Joined May 2017
Photo by Cardiol Therapeutics Inc. (@CardiolRx)Photo by Cardiol Therapeutics Inc. (@CardiolRx)Photo by Cardiol Therapeutics Inc. (@CardiolRx)Photo by Cardiol Therapeutics Inc. (@CardiolRx)Photo by Cardiol Therapeutics Inc. (@CardiolRx)Photo by Cardiol Therapeutics Inc. (@CardiolRx)Photo by Cardiol Therapeutics Inc. (@CardiolRx)Photo by Cardiol Therapeutics Inc. (@CardiolRx)Photo by Cardiol Therapeutics Inc. (@CardiolRx)Photo by Cardiol Therapeutics Inc. (@CardiolRx)
Cardiol Therapeutics Inc. retweeted
Join me at #MPD2026 in Berlin on 23 October for “Pericarditis: Progress, Compromises and Remaining Unanswered Questions”. Let’s discuss the 2025 ESC Guidelines and the next priority: sustained remission with less treatment burden. #Pericarditis
2
8
373
Cardiol Therapeutics Inc. retweeted
Working with pericarditis and myocarditis leaders from around the world at recent investigator meetings @CleClinicHVTI @ACCinTouch @NBE_96
3
1
32
2,760
Cardiol Therapeutics Inc. retweeted
Excellent discussions with fellow investigators advancing the Phase III MAVERIC trial in recurrent pericarditis. Proud that our @MedStarHealth Pericardial Disease Program is contributing to this important study of CardiolRx™ during IL-1 blocker discontinuation. #MAVERIC #Pericarditis
1
3
1
14
2,274
Cardiol Therapeutics Inc. retweeted
Phase II MAVERIC data published in @JAHA_AHA: an oral drug associated with reduced pain, inflammation, and recurrences. Phase III MAVERIC enrolling patients with recurrent pericarditis at @ClevelandClinic and 20 U.S. sites: maveric.cardiolrx.com/#peric… @ACCinTouch @CleClinicHVTI
MAvERIC Trial: In recurrent pericarditis patients treated with synthetic cannabidiol, pericarditis pain and inflammation decreased. @MayoClinicCV ahajrnls.org/44Xhx2R
7
27
2,635
Cardiol Therapeutics Inc. retweeted
($CRDL) Cardiol Therapeutics: The Heart Drug Story Retail Investors Aren't Talking About...Yet! @CardiolRx xitter.gq/i/broadcasts/1mxPaLpdk…
🤝 Paid partnership
16
4
63
494,081
Cardiol Therapeutics Inc. retweeted
Cardiol Therapeutics (CRDL): Poised for Breakthrough in Cardiovascular Treatment - @CardiolRx *Sponsored xitter.gq/i/broadcasts/1ypJdqVkn…
4
10
1
55
88,892
Cardiol Therapeutics Inc. retweeted
There are many things happening in the world of myocarditis and pericarditis, and all of them are looking very positive for patients. Cardiol Therapeutics has been working on Clinical Trials for both of these diseases and so far the outcomes are looking to be very helpful for those suffering, especially with recurrent pericarditis. Read our most recent blog post to find out more! myocarditisfoundation.org/my…
1
3
9
879
Cardiol Therapeutics Inc. retweeted
Days before joining the Washington Capitals, @HLundqvist learned he had heart inflammation which ultimately forced him to conclude his career. Watch #OpenHeart on Netflix to follow his journey & recovery from major heart surgery. @netflix @club30pod @ClevelandClinic
4
11
884
Cardiol Therapeutics Inc. retweeted
Did you miss our Heart Health segment on MSNBC? Watch here! pericarditisalliance.org/msn…
3
3
343
Cardiol Therapeutics Inc. retweeted
La enfermedad CV continua siendo la causa #1 de muerte. La forma más efectiva de prevenirlo es la prevención. Desde edades tempranas. Dieta saludable ejercicio y salud mental son accesibles para todos y la mejor estrategia. @TecSaludMX
1
8
1
41
3,952
Cardiol Therapeutics Inc. retweeted
Cardiac arrest and heart attack are not the same! With cardiac arrest, a person's heart stops unexpectedly. Call 911 and start CPR by pushing hard & fast in the center of the chest. #CPRwithHeart #HeartMonth
31
166
7
263
177,582
Cardiol Therapeutics Inc. retweeted
Covid aumenta el riesgo de enfermedad cardiovascular: infarto, embolias, miocarditis. El estudio LANCER @CardiolRx está buscando determinar si el uso de CBD (farmacéutico) disminuye el riesgo. Seguimos reclutando- @TecSaludMX
13
46
5
229
Cardiol Therapeutics Inc. retweeted
ICYMI: Pericarditis Alliance Q&A Webinar. Hear what national & international pericarditis experts know about pericardial disease, news regarding pericarditis and COVID-19, & so much more! pericarditisalliance.org/wat…
5
5
Cardiol Therapeutics Inc. retweeted
Join us TODAY at 5pm EST for the Pericarditis Alliance Q&A Webinar! Listen to national & international leaders in the pericardial field answer your questions and learn about pericardial disease. Register now & don’t miss out on this special event; us06web.zoom.us/webinar/regi…
3
7
Cardiol Therapeutics Inc. retweeted
Si sufriste covid y tienes riesgo de enfermedad cardiovascular CV-cuídate -en los siguientes 12 meses existe un aumento de numerosos padecimientos CV. Mecanismo más probable inflamación persistente. Nuestro estudio LANCER busca disminuir el riesgo, evalúa efecto de CBD.
3
15
72
Cardiol Therapeutics Inc. retweeted
A recent study found that people who were infected with #COVID19 are at increased risk of heart disease, even a year after their recovery from infection. Listen to Dr. Leslie Cooper discuss Covid related cardiac diseases here: youtube.com/watch?v=3E4HPldX… #myocarditis #pericarditis
2
4
9
Cardiol Therapeutics Inc. retweeted
Compuestos de Cannabis incluyen el CBD y THC. CBD puro ha mostrado: 1. ⬇️replicacion SARS-CoV-2 in vitro 2. ⬇️ inflamación y daño al corazón en animales Tiene potencial para uso clínico en COVID, su uso requiere completar fase clínica, activa actualmente @CardiolRx
1
13
4
64
Cardiol Therapeutics Inc. retweeted
After a #myocarditis diagnosis, there are many actions you can take to help stay healthy. Read our latest blog post to learn more. myocarditisfoundation.org/ti…
2
8